ArticleInternational journal of dermatology2026
Intraoperative Nail Matrix Assessment in Longitudinal Melanonychia.
Article in International journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLongitudinal melanonychia (LM) may represent subungual melanoma (SUM), yet clinical differentiation from benign LM remains challenging. Intraoperative dermoscopy (IOD) improves diagnostic accuracy but requires specialized equipment and time. Intraoperative nail matrix examination (IONME), a direct visual inspection without magnification, may provide a simpler alternative. This study evaluated the diagnostic performance of IONME compared with histopathology and nail plate dermoscopy.
methodsA retrospective analysis of 110 LM cases (16 SUM in situ, 94 benign LM, of which 88 were melanocytic) with documented IONME was performed. IONME patterns were classified into three morphological categories: (a) barely visible homogeneous pigmentation or none, (b) regular lines and/or homogeneous spot, and (c) irregular variegated lines. Each pattern was correlated with histopathology. Diagnostic accuracy, sensitivity, and specificity were calculated by comparing SUM in situ with benign melanocytic LM (mLM). Intra-observer agreement was assessed using Cohen's κ.
resultsAn irregular IONME pattern was observed in 87.5% (14/16) of SUM in situ versus 21.6% (19/91) of benign mLM (p < 0.001), yielding sensitivity of 0.88 and specificity of 0.78. In comparison, nail plate dermoscopy demonstrated lower accuracy (sensitivity, 0.81; specificity, 0.55). The barely visible pattern occurred exclusively in benign LM, while the regular pattern predominated in melanocytic activation and lentigo. Intra-observer agreement for pattern classification was excellent (κ = 0.84-0.88; p < 0.001). Agreement for the presence of an irregular pattern ranged from excellent to perfect (κ = 0.94-1.00; p < 0.001).
conclusionsIONME is a simple, equipment-free intraoperative tool that improves clinicopathologic correlation, aids in distinguishing SUM in situ from benign LM, and supports patient follow-up. It can be easily incorporated into routine LM biopsy documentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.